PHE_Scientific_ Analysis of iPSCs by G-banding
Estimated value
£23k
Awarded value
£23k
Suppliers
1
Lots
1
Published
22 May 2019
Description
Public Health England (PHE) has awarded a contract to Cell Guidance Systems to assess the chromosomal stability of human induced pluripotent stem cells (iPSCs). The service subject to this contract are: - Be able to receive, handle and process live cells that are Advisory Committee on Dangerous Pathogens (ACDP) Hazard Group 2. - Have experience handling and fixing human induced pluripotent stem cells (iPSCs) e.g. identifying colony cultures that are in the log phase of growth. - Use Colcemid for arresting cells in metaphase so that chromosomes can be separated for cytogenetic studies. - Fix the cells using potassium chloride (KCl) solution and 3:1 methanol: acetic acid. - Assess the karyology of the fixed cells by G-banding - at least 20 G-banded metaphase spreads needed for each sample. - Provide a summary of the representative karyotype, along with additional information if any karyotypic abnormalities are found.
Scope
- Reference
- tender_205196/771051
- Total value
- £23,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 21 May 2019 to 20 May 2021
- CPV classifications
- 73111000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 02 May 2019, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£23k
Award date
21 May 2019
Contract start
21 May 2019
Contract end
20 May 2021